Cargando…
Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
No clinical characteristics, particularly not sputum characteristics, can guide antibiotic prescription in patients with mild to severe COPD exacerbations https://bit.ly/3e1JV8o
Autores principales: | van Velzen, Patricia, ter Riet, Gerben, Brinkman, Paul, Sterk, Peter J., Prins, Jan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248336/ https://www.ncbi.nlm.nih.gov/pubmed/32494571 http://dx.doi.org/10.1183/23120541.00099-2020 |
Ejemplares similares
-
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
por: Puhan, Milo A, et al.
Publicado: (2009) -
Assessing Primary Care Physicians’ Beliefs and Attitudes of Asthma Exacerbation Treatment and Follow-Up
por: Loymans, Rik, et al.
Publicado: (2011) -
Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review
por: Puhan, Milo A, et al.
Publicado: (2008) -
Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study
por: Yu, Tsung, et al.
Publicado: (2017) -
Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease
por: Minov, Jordan, et al.
Publicado: (2018)